Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-((4,4-diphenyl-1-piperidinyl)propyl)-5-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate Hydrochloride
2. 3-methyl-5-(3-(4,4-diphenyl-1-piperidinyl)propyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
3. B 844-39
4. B 859-35
5. B8509-035
6. B859-35
7. Dexniguldipine
8. Dnig
9. Niguldipine
10. Niguldipine Fumarate
11. Niguldipine Hydrobromide
12. Niguldipine Maleate
1. 113317-61-6
2. 119934-51-9
3. (+/-)-niguldipine Hydrochloride
4. Niguldipine Hydrochloride, (+/-)-
5. Nsc-617553
6. Niguldipine (hydrochloride)
7. 5qc11tlq7k
8. B-844-39
9. 5-o-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-o-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
10. 134886-09-2 (hcl)
11. Dsstox_cid_26318
12. Dsstox_rid_81534
13. Dsstox_gsid_46318
14. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(3-(4,4-diphenyl-1-piperidinyl)propyl) 5-methyl Ester, Hydrochloride (1:1)
15. 3-(3-(4,4-diphenylpiperidin-1-yl)propyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
16. 3-3-(4,4-diphenyl-1-piperidyl)propyl 5-methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
17. (+/-) -niguldipine Hydrochloride (1:x)
18. Cas-102992-93-8
19. Unii-5qc11tlq7k
20. Niguldipine Hcl
21. Dexniquldipine Hcl
22. Dl-niguldipine Hydrochloride
23. Schembl9001404
24. Chembl1965632
25. Dtxsid20872307
26. Tox21_112014
27. Nsc617553
28. Tox21_112014_1
29. Ccg-207993
30. Ncgc00025014-03
31. 134886-09-2
32. J-002947
33. Q27262742
34. 102992-93-8
35. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[3-(4,4-diphenyl-1-piperidinyl)propyl] 5-methyl Ester, Xhydrochloride
36. 3-(4,4-diphenylpiperidin-1-yl)propyl Methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrogen Chloride (1:1)
37. 3-methyl 5-[3-(4,4-diphenyl-1-piperidinyl)-propyl] (-)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate Hydrochloride
38. 3-methyl 5-[3-(4,4-diphenylpiperid-1-yl)-propyl] (+)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate Hydrochloride
| Molecular Weight | 646.2 g/mol |
|---|---|
| Molecular Formula | C36H40ClN3O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | 645.2605637 g/mol |
| Monoisotopic Mass | 645.2605637 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
ABOUT THIS PAGE
59
PharmaCompass offers a list of Nsc-617553 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nsc-617553 manufacturer or Nsc-617553 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nsc-617553 manufacturer or Nsc-617553 supplier.
PharmaCompass also assists you with knowing the Nsc-617553 API Price utilized in the formulation of products. Nsc-617553 API Price is not always fixed or binding as the Nsc-617553 Price is obtained through a variety of data sources. The Nsc-617553 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nsc-617553 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nsc-617553, including repackagers and relabelers. The FDA regulates Nsc-617553 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nsc-617553 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nsc-617553 supplier is an individual or a company that provides Nsc-617553 active pharmaceutical ingredient (API) or Nsc-617553 finished formulations upon request. The Nsc-617553 suppliers may include Nsc-617553 API manufacturers, exporters, distributors and traders.
Nsc-617553 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nsc-617553 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nsc-617553 GMP manufacturer or Nsc-617553 GMP API supplier for your needs.
A Nsc-617553 CoA (Certificate of Analysis) is a formal document that attests to Nsc-617553's compliance with Nsc-617553 specifications and serves as a tool for batch-level quality control.
Nsc-617553 CoA mostly includes findings from lab analyses of a specific batch. For each Nsc-617553 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nsc-617553 may be tested according to a variety of international standards, such as European Pharmacopoeia (Nsc-617553 EP), Nsc-617553 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nsc-617553 USP).
